搜索
Sophia Genetics SA
SOPH添加自选
7.870USD
0.0000.00%
交易中 09/14, 14:36（美东）
669.96M总市值
亏损市盈率 TTM
关于 Sophia Genetics SA 公司
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Sophia Genetics SA 简介
公司代码SOPH
公司名称Sophia Genetics SA
上市日期Jul 23, 2021
CEOCamblong (Jurgi)
员工数量423
证券类型Ordinary Share
年结日Jul 23
公司地址La Piece 12
城市ROLLE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Switzerland
邮编CH-1180
电话41216941060
网址https://www.sophiagenetics.com/
公司代码SOPH
上市日期Jul 23, 2021
CEOCamblong (Jurgi)
Sophia Genetics SA公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
443.79K
-12.17%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
443.79K
-12.17%
Mr. Troy M. Cox
Mr. Troy M. Cox
Independent Director
Independent Director
294.96K
+6.69%
Mr. Troy M. Cox
Mr. Troy M. Cox
Independent Director
Independent Director
294.96K
+6.69%
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
常见问题
Sophia Genetics SA的前五大股东是谁？
Sophia Genetics SA 的前五大股东如下：Dr. Jurgi Camblong, Ph.D.
有多少机构持有Sophia Genetics SA(SOPH)的股份？
截至2026Q1，共有89家机构持有Sophia Genetics SA的股份，合计持有的股份价值约为27.73M，占公司总股份的38.63%。与2025Q4相比，机构持股有所增加，增幅为-11894064.00。